Articles

BioAffinity received roughly $7.7 million in warrant exercises, bringing a cash infusion to the otherwise challenged BIAF stock. More

These are the top consumer stocks to sell before things get worse. These companies are struggling with issues that will take years to fix. More

Here are 3 penny stocks to buy that should realistically benefit from more bullish sentiment in the near future, should a recovery begin. More

These three undervalued bank stocks deserve your attention in October. C, DFS and GS will provide long-term investors with good returns. More

While these market ideas may be flying under the radar, certain small-cap sleeper stocks to buy pack quite the punch. More

Members of the European Central Bank are leaping to defend its decision to give Amazon a large role in shaping the digital euro CBDC. More

Biogen produced an outstanding Phase 3 result for its Alzheimer’s treatment, sending associated biotech stocks soaring. More

Subscriber Sign in